Genome‐wide association studies (GWAS) have identified a strong association of the locus for the cyclin‐dependent kinase inhibitor 2A/B (CDKN2A/B) with a multitude of age‐related diseases, including atherosclerosis and its related complications (Hannou et al. 2015). Here, CDKN2A is linked to atherosclerosis.